The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s G-Protein Coupled Receptors Global Market Report 2024, the G-protein coupled receptors market is expected to show significant growth in the forecast period.

The G-protein-coupled receptors (GPCR) market has witnessed robust growth in recent years, with significant projections for the future.

• Historical Growth Factors:
  • Advances in drug discovery.
  • FDA approvals.
  • Genomic discoveries.
  • Emerging markets.
  • Market consolidation.
  • Growing aging population.
• Future Growth Projections:
  • Expected to reach $3.18 billion in 2024.
  • Compound Annual Growth Rate (CAGR) of 7.1%.
  • Estimated to grow to $4.09 billion by 2028.
  • CAGR of 6.5%.
• Factors Driving Forecasted Growth:
  • Personalized medicine.
  • Focus on rare diseases.
  • Artificial intelligence in drug discovery.
  • Patient-centric drug development.
  • Environmental and social factors.
  • Biosimilar market growth.

View More On The G-Protein Coupled Receptors Market Report 2024 – https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

 Cancer Prevalence Fueling Market Expansion

• The rising prevalence of cancer is a significant driver of growth in the GPCR market.
• GPCRs control various cancer-related processes, including proliferation, metastasis, and apoptosis resistance.
• Statistics from organizations like ASCO and the Breast Cancer Research Foundation underline the increasing incidence of cancer.
• Major companies in the market include Pfizer Inc., Roche Holding AG, and Novartis International AG.

Lifearc Ventures Backs Maxion Therapeutics And Septerna Inc. To Propel G-Protein-Coupled Receptor Research

• Investment in GPCR screening and antibody development is a growing trend.
• LifeArc Ventures’ investment in Maxion Therapeutics and Septerna Inc. demonstrates increasing interest and support for GPCR-related research.
• Maxion Therapeutics focuses on antibody development for ion channel and GPCR-driven disorders.
• Septerna Inc. is working on innovative GPCR-targeted medication programs using its Native Complex Platform.

Eurofins Scientific Strengthens Drug Discovery Arm With Acquisition Of Beacon Discovery

• Eurofins Scientific’s acquisition of Beacon Discovery in February 2021 expands its drug discovery capabilities.
• Beacon Discovery specializes in GPCR research, aligning with Eurofins’ strategy to support pharmaceutical industry partners.
• The acquisition broadens Eurofins’ product portfolio in ADMET, in vitro pharmacology, and chemistry services.

Market Segmentation and Regional Outlook

• Market Segments:
  • By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands.
  • By Assay: Various functional assays and binding assays.
  • By Applications: Cancer Research, CNS Research, Metabolic Research, and more.
• Regional Outlook:
  • North America led the market in 2023.
  • Asia-Pacific expected to witness the fastest growth in the forecast period.

In conclusion, the G-protein-coupled receptors market is poised for substantial growth driven by factors such as cancer prevalence, increased investment in research and development, and strategic acquisitions. As advancements in biotechnology, digital therapeutics, and collaborative efforts continue, the market is expected to expand further, offering promising opportunities for stakeholders across the pharmaceutical and biotechnology sectors.

Request A Sample Of The Global G-Protein Coupled Receptors Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=11976&type=smp